benzyl 3-amino-4-hydroxy-benzoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl 3-amino-4-hydroxy-benzoate
• 英文别名: Benzyl 3-amino-4-hydroxybenzoate
• 化学式: C₁₄H₁₃NO₃
• 分子量: 243.262
• InChiKey: WHCJTNYMYQLGDN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  benzyl 3-amino-4-hydroxy-benzoate 在 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 反应 12.0h， 生成
  参考文献：
  名称：

  Synthetic nanoparticles for selective hydrolysis of bacterial autoinducers in quorum sensing

  摘要：

  N-acyl homoserine lactones (AHLs) are signal molecules used by a large number of gram-negative bacteria in quorum sensing and their hydrolysis is known to inhibit biofilm formation. Micellar imprinting of AHL-like templates with catalytic functional monomers yielded water-soluble nanoparticles with AHL-shaped active site and nearby catalytic groups. Either Lewis acidic zinc ions or nucleophilic pyridyl ligands could be introduced through this strategy, yielding artificial enzymes for the hydrolysis of AHLs in a substrate-selective fashion.

  DOI：

  10.1016/j.bmcl.2019.02.016
• 作为产物：
  描述：

  对羟基苯甲酸苄酯 在 乙醇 、 aluminium amalgam 、 硝酸 作用下， 生成 benzyl 3-amino-4-hydroxy-benzoate
  参考文献：
  名称：

  Synthetische Studien über die Beziehung zwischen chemischer Konstitution und antimikrober Wirkung XII. 3-Nitro- und 3-Amino-4-oxy bzw. alkoxybenzoesäureester

  摘要：

  DOI：

  10.1002/ardp.19342721022

文献信息

• [EN] TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSÉS MODULATEURS DE TLR2, COMPOSITIONS PHARMACEUTIQUES ET LEURS UTILISATIONS
  申请人：AXIAL THERAPEUTICS INC

  公开号：WO2021242923A1

  公开（公告）日：2021-12-02

  The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.

  本公开涉及调节Toll样受体（TLR）蛋白活性的化合物，包括激动剂或激活剂、部分激动剂和拮抗剂。特别感兴趣的是调节TLR2活性的化合物，以及使用这些化合物治疗与TLR2通路相关的癌症和其他疾病的方法。
• NOVEL HETEROCYCLIC AMIDE COMPOUNDS AND MEDICINAL USES THEREOF
  申请人：YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.

  公开号：EP0940400A1

  公开（公告）日：1999-09-08

  A heterocyclic amide compound of the formula (I) wherein each symbol is as delined in the specification, a pharmacologically acceptable salt thereof, a pharmaceutical composition thereof and a pharmaceutical use thereof. The heterocyclic amide compound and a pharmacologically acceptable salt thereof of the present invention have superior inhibitory action on chymase group in mammals inclusive of human, and can be administered orally or parenterally. Therefore, they are useful as chymase inhibitors and can be used for the prophylaxis and treatment of various diseases caused by chymase, such as those caused by angiotensin II.

  一种式 (I) 的杂环酰胺化合物 其中各符号如说明书中所述、其药理学上可接受的盐、其药物组合物和其药物用途。本发明的杂环酰胺化合物及其药理学上可接受的盐对哺乳动物（包括人类）的糜蛋白酶基团具有优异的抑制作用，可以口服或肠外给药。因此，它们可作为糜蛋白酶抑制剂，用于预防和治疗由糜蛋白酶引起的各种疾病，如血管紧张素 II 引起的疾病。
• Novel type of plasmin inhibitors: Providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidine
  作者：Naoki Teno、Keigo Gohda、Keiko Wanaka、Yuko Tsuda、Maiko Akagawa、Eriko Akiduki、Mitsuhito Araki、Arisa Masuda、Tadamune Otsubo、Yukiko Yamashita

  DOI：10.1016/j.bmc.2015.04.013

  日期：2015.7

  Here we report a series of plasmin inhibitors which were originally derived from the parent structure of 1 and 2. Our efforts focused on the optimization of the P4 moiety of 2 and on the quest of alternative scaffold to pyrrolopyrimidine in the parent compounds. The results of the former gave us pivotal information on the further optimization of the P4 moiety in plasmin inhibitors and those of the latter revealed that appropriate moieties extending from the benzimidazole scaffold engaged with S4 pocket in the active site of plasmin. (C) 2015 Elsevier Ltd. All rights reserved.
• US6080738A
  申请人：——

  公开号：US6080738A

  公开（公告）日：2000-06-27
• WO2024097355A1
  申请人：——

  公开号：——

  公开（公告）日：——